How MDM2 Inhibition May Help Patients With MPNs Who Have Progressed to AML
doctor explains how genetics and new drug combinations are changing and advancing the MPN treatment landscape.
Related Articles
‘Depression Rooms’ and ‘Doom Piles’: Why Clearing the Clutter Can Feel Impossible
The link between messiness and mental health is real. These low-lift tips for keeping a clean-enough home will help.
Should CLL Patients Get a Flu Shot?
Many chronic lymphocytic leukemia (CLL) patients have compromised immune systems, making a flu shot an important protective measure to take. Learn more.
Patient Power
Patient Power. 23,118 likes · 1,977 talking about this. Resources to build the confidence, knowledge and hope to live well with cancer. Join us here…
Patient Experience Joining a Clinical Trial
What is it like to join a clinical trial? Two CLL patients share what brought them to a clinical trial, what their participation entail, and…
How Can I Maintain a Healthy Lifestyle During Cancer Treatment?
New guidelines are available on diet and exercise during treatment for cancer.
Diagnosed Young With Multiple Myeloma
A doctor and patient advocate discuss the unique challenges of being diagnosed with multiple myeloma at a young age.
Survey Identifies Common Gaps in Lung Cancer Knowledge
A survey conducted by the Global Lung Cancer Coalition (GLCC) has identified the many gaps in knowledge between lung cancer patients and doctors.
What Do Biomarkers Mean for NSCLC Patients?
Hear an expert explain what biomarker test results mean for patients with non-small cell lung cancer (NSCLC).
ASH 2021: Treating Relapsed/Refractory Multiple Myeloma
Dr. Krina Patel explains how to make informed treatment decisions for patients with relapsed/refractory multiple myeloma and other updates from ASH 2021.